logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Recent developments in C3-targeted complement therapeutics

delete2022-03-01
delete3
PRE
AI
D
Dimitrios C. Mastellos *
J
John D. Lambris
DOI：10.1016/j.smim.2022.101645delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
INHIBITOR
C3
DEFICIENCIES
COMPSTATIN
SYSTEM

Journal

Seminars in Immunology cover
Seminars in Immunology
IF:
7.8
Papers:
1.6K
Citations:
7.3K

Organization

U
university of pennsylvania
Scholars:
9.2W
Papers: 7.8W
Citations: 153
N
National Centre of Scientific Research Demokritos
Scholars:
4.4K
Papers: 3.9K
Citations: 3.3K
Cited Papers

Cited Papers

Complement activation in cancer: Effects on tumor-associated myeloid cells and immunosuppression
errSEMINARS IN IMMUNOLOGY
IF7.8
err2022-03-01
err22
PREAI
errMagrini, Elena; Minute, Luna; Dambra, Monica; Garlanda, Cecilia
errShare
errSave
Chirp Impulse Radio Ultra-Wideband antenna array with low sample-rate digital beam steering
err2013 IEEE 24th Annual International Symposium on Personal, Indoor, and Mobile Radio Communications (PIMRC)
IF0
err2013-09-01
err0
PREAI
errIgor Dotlic; Ryu Miura
errShare
errSave
Clinical promise of next-generation complement therapeutics
errNATURE REVIEWS DRUG DISCOVERY
IF101.8
err2019-07-19
err247
errOAAI
errMastellos, Dimitrios C.; Ricklin, Daniel; Lambris, John D.
errShare
errSave
Complement - tapping into new sites and effector systems
errNATURE REVIEWS IMMUNOLOGY
IF60.9
err2014-11-14
err275
PREAI
errKolev, Martin; Le Friec, Gaelle; Kemper, Claudia
errShare
errSave
Avacopan for the Treatment of ANCA-Associated Vasculitis
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2021-02-18
err567
errOAAI
errJayne, David R. W.; Merkel, Peter A.; Schall, Thomas J.; Bekker, Pirow
errShare
errSave
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
errCLINICAL AND EXPERIMENTAL IMMUNOLOGY
IF3.8
err2004-10-28
err294
errOAAI
errHarboe, M; Ulvund, G; Vien, L; Fung, M; Mollnes, TE
errShare
errSave
Patching the internet of things
errIEEE Spectrum
IF0
err2017-11-01
err0
PREAI
errSandip Ray; Abhishek Basak; Swarup Bhunia
errShare
errSave
The renaissance of complement therapeutics
errNATURE REVIEWS NEPHROLOGY
IF39.8
err2017-12-04
err306
errOAAI
errRicklin, Daniel; Mastellos, Dimitrios C.; Reis, Edimara S.; Lambris, John D.
errShare
errSave
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin
errJOURNAL OF MEDICINAL CHEMISTRY
IF6.8
err2006-07-04
err124
PREAI
errKatragadda, Madan; Magotti, Paola; Sfyroera, Georgia; Lambris, John D.
errShare
errSave
Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery
errTRENDS IN IMMUNOLOGY
IF13.9
err2017-06-01
err33
errOAAI
errMastellos, Dimitrios C.; Reis, Edimara S.; Ricklin, Daniel; Smith, Richard J.; Lambris, John D.
errShare
errSave
researcher View more